fda approval semaglutide mash Approves to Treat With Moderate to Advanced Fibrosis FDA Approval of Semaglutide for

For semaglutide, the majority of (gastrointestinal) side-effects are mild to moderate in severity and of short duration, she said

The differences come down to regulation, cost, and how you access them

Pausing GLP-1 medications can lead to the return of symptoms or conditions they're prescribed to manage

And GLP-1s do come with side effects that for some patients have been serious enough to lead to discontinuation

Talk to your doctor before starting any new diet, especially one that cuts out entire food groups

Real-world Effectiveness Beyond clinical trials, real-world data supports the effectiveness of semaglutide